UK health technology assessment body guiding NHS decisions
Prime Minister Benjamin Netanyahu has disclosed that doctors found a tiny, early-stage malignant tumor during routine follow-up after 2024 prostate surgery and that targeted radiation therapy has removed it. He has said he delayed publishing the report by two months to avoid fuelling Iranian misinformation during recent clashes. Doctors at Hadassah Medical Center have reported imaging and blood tests showing no remaining disease.
A roundup of recent cancer breakthroughs highlights new immunotherapies, targeted drugs and surgical-sparing treatments. The Independent reports on Scolyer’s pioneering work and a landmark NICE decision; The Guardian covers durvalumab’s promise in bladder cancer; Business Insider UK and Reuters summarize ASCO findings on pancreatic and colon cancers, among others.
Nice has issued a draft guideline for PMOS that mandates annual checks, earlier diagnosis, and monitoring of long-term risks. It renames the condition from PCOS to PMOS to reflect broader health impacts. It also rules out laser hair removal as a cost-ineffective treatment, instead urging contraception-based management and IVF options where appropriate.